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Abstract: In the last 10 years, biodegradable aliphatic polyesters, such as poly(lactic-co-glycolic 
acid) (PLGA), have attracted increasing attention for their use as scaffold materials in bone tissue 
engineering because their degradation products can be removed by natural metabolic pathways. 
However, one main concern with the use of these speciﬁ  c polymers is that their degradation 
products reduce local pH, which in turn induces an inﬂ  ammatory reaction and damages bone 
cell health at the implant site. Thus, the objective of the present in vitro study was to investigate 
the degradation behavior of PLGA when added with dispersed titania nanoparticles. The results 
of this study provided the ﬁ  rst evidence that the increased dispersion of nanophase titania in 
PLGA decreased the harmful change in pH normal for PLGA degradation. Moreover, previ-
ous studies have demonstrated that the increased dispersion of titania nanoparticles into PLGA 
signiﬁ  cantly improved osteoblast (bone-forming cell) functions (such as adhesion, collagen 
synthesis, alkaline phosphatase activity, and calcium-containing minerals deposition). In this 
manner, nanophase titania–PLGA composites may be promising scaffold materials for more 
effective orthopedic tissue engineering applications.
Keywords: nanocomposites, tissue engineering scaffolds, polymer/ceramic composites, nano-
phase titania, degradation, poly(lactic-co-glycolic acid)
Introduction
The use of biodegradable polyesters in orthopedic devices for proper ﬁ  xation of long 
bone fractures was ﬁ  rst clinically implemented in Finland in 1984 (Rokkanen et al 
1985). It was demonstrated that the exact union of the fracture ﬁ  xed by poly(lactic-co-
glycolic acid) (PLGA) was 5 days faster than the fracture ﬁ  xed by conventional metallic 
implants (Rokkanen et al 1985). Since the 1990s, the applications of poly(glycolic 
acid) (PGA), poly(lactic acid) (PLA), and their copolymers (PLGA) in bone tissue 
engineering have been investigated extensively (Gunatillake and Adhikari 2003). 
Importantly, these polymers (PLA, PGA, and PLGAs) have been approved by the 
US Food and Drug Administration (FDA) for certain human clinical applications 
because their degradation products are nontoxic, endogenous natural metabolites, 
and are eventually eliminated from the body in the form of carbon dioxide and water 
(Ratner 2004).
However, one main concern for the use of these polymers in bone tissue engineering 
is that their intermediate degradation products (speciﬁ  cally, lactic acid and/or glycolic 
acid) by non-enzymatic hydrolysis of ester bonds in their backbone reduces the local 
pH, which in turn induces an inﬂ  ammatory reaction and damages bone cell health at 
the implant site. Moreover, the rapid drop of pH in vivo may accelerate the polymer’s 
degradation rate, thus, resulting in premature loss of mechanical properties before new 
bone formation occurs. Therefore, it is critical to decrease the adverse effects of PLGA International Journal of Nanomedicine 2006:1(4) 542
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degradation (speciﬁ  cally,  pH drop) before this biomaterial can 
be used more effectively in orthopedic applications.
In this light, it has been reported that ceramic particles 
(such as Bioglass® and hydroxyapatite) used as additives 
to PLGA can provide a pH buffering effect at the polymer 
surface and, thus, avoid an unfavorable environment for 
new bone growth (Zhang and Ma 2000; Maquet et al 2004). 
Speciﬁ  cally, such studies have shown that the pH of the 
media containing PLGA–hydroxyapatite foams dropped 73% 
less than the pH of the media containing control PLGA foams 
after 50 days of incubation. In addition, the pH of the media 
containing PLGA–Bioglass® foams dropped 3% less than the 
pH of the media containing control PLGA foams after 30 days 
of incubation. However, the inﬂ  uence of titania nanoparticle 
addition and its dispersion status on the degradation kinetics 
of PLGA have not been completed so far. Titania is a key 
orthopedic implant material since it is the oxide that readily 
forms on the widely implanted titanium. It is hypothesized 
that the addition of titania nanoparticles to PLGA may 
decrease the degradation rate of PLGA by interfering with 
water and acidic oligomer diffusion and, thus, decreasing 
harmful pH variations during degradation.
Therefore, to provide a complete story of the usefulness of 
nanophase titania/PLGA composites to improve orthopedic 
implant effectiveness, the objective of the present study 
was to investigate the degradation behavior of PLGA as 
inﬂ  uenced by the dispersion of titania nanoparticles.
Materials and methods
Materials Preparation
PLGA pellets (50/50 wt % poly(dl-lactic/glycolic acid); 
Polysciences, Warrington, PA, USA) were dissolved in chlo-
roform while nanophase titania powder (Nanophase Tech-
nologies, Romeoville, IL, USA) was then added to the PLGA 
solution to give a 30/70 ceramic/polymer weight ratio. The 
composite mixture was then sonicated using a W-380 sonica-
tor (Heat Systems - Ultrasonics, Farmingdale, NY, USA) with 
output power settings at 118.75 W, 166.25 W, 213.75 W, and 
332.5 W (termed PTC25, PTC35, PTC45, and PTC70  respec-
tively). After sonication, the suspension was cast into a Teﬂ  on 
petri dish, evaporated in air at room temperature for 24 hours 
and dried in an air vacuum chamber at room temperature for 48 
hours. The schematic procedure for nanophase titania–PLGA 
composite fabrication is shown in Figure 1.
Pure PLGA and nanophase titania compacts were used 
as controls. Nanophase titania compacts were prepared by 
dry pressing titania powders in a tool-steel die via a uniaxial 
pressing cycle from 0.6 to 3 GPa over a 10-minute period. 
The green (unsintered) titania compacts were then heated in 
air at a rate of 10°C/minute from room temperature to a ﬁ  nal 
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Figure 1 The schematic procedure for nanophase titania–PLGA composite preparation.International Journal of Nanomedicine 2006:1(4) 543
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temperature of 600°C, sintered at 600°C for 2 hours, and 
were cooled down at the same rate as the heating rate. These 
compacts were termed sintered titania compacts (TCS).
Material characterization
Surface topographies of the nanophase titania/PLGA 
composites were characterized according to standard 
scanning electron microscopy techniques using a JEOL 
JSM-840 Scanning Electron Microscope (SEM) at a 5 kV 
accelerating voltage. Substrates were sputter-coated with 
a thin layer of gold-palladium using a Hummer I Sputter 
Coater (Technics, Alexandria, VA, USA) in a 100-millitorr 
vacuum argon environment for 3 minutes with 0.01 Amp of 
current. SEM images taken at 15 kX magniﬁ  cation were used 
to determine differences in topography and titania surface 
coverage of the nanophase titania–PLGA composites.
Degradation experiments
For degradation experiments, 12 specimens with dimensions 
of 10 mm × 10 mm × 3 mm were used for each composite 
and control sample. These specimens were divided into 3 sets 
according to incubation times. Initial dry substrates of interest 
were weighed (W0) and sterilized. Then, all the substrates 
were immersed into phosphate buffered saline (PBS; a solu-
tion containing 8 g NaCl, 0.2 g KCl, 1.5 g Na2HPO4, and 
0.2 g KH2PO4 in 1000 mL deionized water adjusted to a pH 
of 7.4; all chemicals from Sigma) and were incubated under 
standard cell culture conditions, that is, a 37°C, 5% CO2/95% 
air environment. Blank PBS, without substrates, was used as a 
reference. After 21, 28, and 35 days, specimens were removed 
from PBS, abundantly rinsed with deionized water to remove 
the soluble inorganic salt, and dried in an air vacuum chamber 
at room temperature for 48 hours to reach constant mass. 
At each time point, samples were weighed (Wt) and the 
percentage of weight loss (%WL) with respect to incubation 
time was calculated according to the following equation. In 
the results, the %WL was normalized to the amount of PLGA 
in the composites since titania does not degrade.
  %WL
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0
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−
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The pH of the supernatant buffer was monitored three 
times a week during the experiments using a Corning 430 
pH meter (Corning Incorporated, Acton, MA, USA).
Statistical analysis
Numerical data were analyzed using standard analysis of variance 
(ANOVA) techniques followed by a global F test and a Student 
t test; statistical signiﬁ  cance was considered at p0.05.
Results
Material characterization
Titania particles of different agglomeration sizes were 
visible on the surface of the composites, as shown in 
Figure 2. Scanning electron micrographs suggested that 
the distribution of ceramic particles was different on the 
surface of the composites depending on the sonication 
power utilized; speciﬁ  cally,  there were more titania particles 
on the surface of each composite after sonication with 
higher power. Finer titania particles were also observed 
on the surface with increasing sonication powers. That is, 
larger ceramic agglomerations tended to break into smaller 
particles in the polymer solution after higher powers of 
sonication. Because of this, the amount of surface area 
occupied by titania increased on the surface of the compos-
ites with higher sonication powers. Speciﬁ  cally, 10.6%, 
10.2%, and 10.1% compared with 5.7% of the surface area 
occupied was titania on the PTC70, PTC45, PTC30, and 
PTC25 composites, respectively. At higher sonication pow-
ers, titania particles became smaller and were more evenly 
dispersed in the PLGA matrix. However, there were no 
signiﬁ  cant differences in terms of titania surface coverage 
for PTC45 and PTC70 compared with PTC35.
PTC25 PTC35
PTC70
TCS
PTC45
PLGA
Figure 2 Representative SEM micrographs of nanophase titania–PLGA composites: 
PTC25, PTC35, PTC45, and PTC70; and control materials: PLGA and TCS. Original 
magniﬁ  cation: 15 kX; magniﬁ  cation bars at the bottom-right corner: 1 μm.
Abbreviations: PLGA, poly(lactic-co-glycolic acid);   TCS, sintered titania compacts.International Journal of Nanomedicine 2006:1(4) 544
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Decreased degradation for nanophase 
titania–PLGA composites
Results of the degradation study showed that the weight 
loss percentage of pure PLGA was the greatest among all 
the substrates tested after respective days (Figure 3). As 
expected, no weight loss was observed on titania compacts. 
Speciﬁ  cally, the weight loss of PTC35, PTC45, and PTC70 
was approximately 20% less than pure PLGA at 21 days of 
incubation; 30% less than pure PLGA at 28 days of incuba-
tion; and 50% less than pure PLGA after 35 days of incuba-
tion. Among all the composites, the weight loss of PTC25 
was greater than the others at 35 days of incubation. This 
indicated that the dispersion status of nanophase titania in 
PLGA played an important role in decreasing the degradation 
behavior of these nanocomposite.
Moreover, the buffering effect of titania particles towards 
PLGA weight loss was more signiﬁ  cant after longer time 
periods of incubation; this correlated to the pH buffering 
effect of titania particles. Speciﬁ  cally, the pH drop was less 
than 16% for all the composites during the ﬁ  rst 21 days of 
incubation while it was 19% for pure PLGA (Figure 4). 
During 22 to 35 days of incubation, the pH drop for all the 
composites and PLGA was faster than the ﬁ  rst 3 weeks of 
incubation. Speciﬁ  cally, the pH drop was 70% for pure PLGA 
while it was 68% for PTC25, 56% for PTC35, and only 43% 
for PTC70 after 35 days of incubation.
Discussion and conclusions
The PLGA degradation process involves three steps that 
begin at the outer perimeter of the scaffolds and moves gradu-
ally into the interior, followed by catastrophic disintegration 
(Wise 2000). In step 1, water diffuses into the polymer chain 
and hydrolytic random chain scission of ester bonds begins. 
Since it undergoes hydrolytic cleavage, PLGA has more 
predictable degradation rates in vivo than polymers whose 
degradation is mediated predominantly by enzymes; this is 
because the levels of enzymatic activity may vary widely 
not only among different patients but also among different 
implantation sites. But the availability of water is virtu-
ally constant in all soft/hard tissues and varies little from 
patient to patient. In step 2, the molecular weight decreases 
and low-molecular-weight oligomers in the inner part of 
the matrix begin to diffuse out of the thinning outer layer. 
At this stage, an acidic environment is formed. When the 
molecular weight of these oligomers is low enough to allow 
solubilization in the medium, weight loss begins. In the ﬁ  nal 
step 3, a polymer shell remains after the oligomers solubilize 
and slow degradation of the shell takes place. Degradation 
of PLGA demonstrates random scission mode under normal 
conditions (ie, in water or phosphate buffer medium of pH 7.4 
at 37°C), while unzipping mode (chain-end scission) under 
harsh conditions (such as high acidity, high temperature, or 
high energy radiation) (Shih 1995).
This study provided the ﬁ  rst evidence that nanophase 
titania dispersed in PLGA can improve the structural 
stability, buffer the harmful pH variations, and decrease 
the weight loss of the scaffolds. The possible reasons are 
that titania nanoparticles dispersed in PLGA may hinder 
water diffusion into the polymer chain and, thus, slow down 
hydrolytic cleavage; moreover, titania nanoparticles may 
interfere with the diffusion of intermediate degradation 
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Figure 3 Percentage weight loss for PTC25, PTC35, PTC45, PTC70, PLGA, and TCS 
incubated in PBS under standard incubation conditions.     Values are mean ± SEM; 
n = 3;  *p<0.05 compared with PLGA at respective days; #p<0.05 compared to all the 
composites at respective days; **p<0.05 compared with PTC25 at respective days; 
+p<0.05 compared with respective materials at earlier days.
Abbreviations: PLGA, poly(lactic-co-glycolic acid);   TCS, sintered titania compacts.
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Figure 4 pH variation with incubation time for PTC25, PTC35, PTC45, PTC70, 
PLGA, and TCS incubated in PBS under standard incubation conditions.
Abbreviations: PBS, phosphate-buffered saline; PLGA, poly(lactic-co-glycolic acid); 
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products (oligomers) out of the polymer, thus, slowing down 
the pH drop. The buffering effect of titania particles on pH 
was more signiﬁ  cant at the later stage of the degradation, 
that is, after 21 days of incubation. At the early stage of 
degradation, the pH reduction might be attributed to the 
residual monomers and oligomers in the original PLGA. The 
signiﬁ  cant pH drop started when the molecular chain was 
small enough to be able to diffuse out of the scaffold into 
the PBS solution. Data demonstrated that the dispersion of 
nanophase titania in PLGA decreased the degradation rate 
of PLGA which may be favorable to new bone growth.
Moreover, previous studies have demonstrated that the 
increased dispersion of titania nanoparticles into PLGA 
significantly enhanced osteoblast (bone-forming cell) 
functions (such as adhesion, collagen synthesis, alkaline 
phosphatase activity, and calcium-containing minerals 
deposition) (Liu et al 2005a, b). Mechanical advantages 
of combining nanophase titania into PLGA have also been 
reported (McManus et al 2005). Speciﬁ  cally, the bending 
modulus of composites of PLA with 50 wt. % nanophase 
(100 nm) titania was signiﬁ  cantly greater than respec-
tive composite formulations with conventional coarser 
grained titania. That is, compared to a bending modulus 
of 60 ± 3 MPa for plain PLA and 870 ± 30 MPa for con-
ventional titania/PLA composites, the bending modulus of 
nanophase titania–PLA composites was 1960 ± 250 MPa, 
which was in the same order of magnitude as trabecular bone. 
In this manner, nanophase titania/PLGA composites may be 
promising scaffold materials for more effective orthopedic 
tissue engineering applications.
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